跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,440 条关于
“Guangdong Zhongsheng Pharmaceutical”
全部
13,440
临床试验
568
药物
1,766
机构
2,195
资讯
8,911
10个月前
Zhongsheng Pharmaceutical Advances Pediatric Angladivir Granules to Phase III for Influenza A Treatment
去年
Everest Medicines Launches VELSIPITY® for Ulcerative Colitis in Greater Bay Area
去年
Everest Medicines Launches VELSIPITY® for Ulcerative Colitis in Greater Bay Area
2个月前
Ivonescimab Outperforms Keytruda in Head-to-Head Phase III Trial, Signaling China's Biotech Ascent from the Greater Bay Area
5个月前
SBP Group's M701 Bispecific Antibody Receives NDA Acceptance for Malignant Ascites Treatment
去年
EUDA Secures Distribution Rights for T-Cell Immunotherapy in Malaysia at $8,000 Per Treatment
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
Pharmaceutical R&D Highlights: Key Clinical Updates from November 2024
2个月前
China's Lab Monkey Prices Surge to Pandemic-Era Highs, Disrupting Drug R&D Studies
去年
Lilly Expands Obesity Treatment Pipeline Through KeyBioscience Collaboration
第 1 页，共 892 页
上一页
下一页
